The selection of cell lines was based on a good representation of:

  1. Cancer gene mutations – according to occurrence in patients
  2. Tissue types – currently 25

Other selection criteria are the growth characteristics of the cell lines and the absence of restrictions for use. We have a commercial licence from the ATCC for all cell lines in the Oncolines™ panel.